Prophylaxis and Treatment of CMV Infections in Transplantation
- 1 January 1996
- book chapter
- Published by Springer Nature
- Vol. 394, 117-134
- https://doi.org/10.1007/978-1-4757-9209-6_13
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Controlled trial of prophylactic versus therapeutic use of ganciclovir after liver transplantation in adultsJournal of Medical Virology, 1993
- Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case-controlled studyJournal of Medical Virology, 1993
- A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow TransplantsNew England Journal of Medicine, 1991
- A Randomized, Placebo-Controlled Trial of Oral Acyclovir for the Prevention of Cytomegalovirus Disease in Recipients of Renal AllograftsNew England Journal of Medicine, 1989
- SYMPTOMATIC CYTOMEGALOVIRUS INFECTION IN SEROPOSITIVE KIDNEY RECIPIENTS: REINFECTION WITH DONOR VIRUS RATHER THAN REACTIVATION OF RECIPIENT VIRUSThe Lancet, 1988
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- In vitro susceptibility of cytomegalovirus isolates from immunocompromised patients to acyclovir and ganciclovirDiagnostic Microbiology and Infectious Disease, 1987
- Cytotoxic T Cells in Cytomegalovirus InfectionNew England Journal of Medicine, 1982
- CYTOMEGALOVIRUS IMMUNE GLOBULINTransplantation, 1979